A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with untreated acute myeloid leukemia (AML) Meeting Abstract
| Authors: | Atallah, E.; Berger, M.; Jurcic, J.; Roboz, G.; Tse, W.; Mawad, R.; Rizzieri, D.; Begna, K.; Orozco, J.; Craig, M.; Yair Levy, M.; Finn, L.; Sharif, K.; Perl, A.; Park, J. |
| Abstract Title: | A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with untreated acute myeloid leukemia (AML) |
| Meeting Title: | 11th International Symposium on Targeted-Alpha-Therapy (TAT11) |
| Keywords: | aged; antibodies, monoclonal -- therapeutic use; ontario; leukemia, myeloid, acute -- drug therapy -- in old age; elements, radioactive -- therapeutic use; congresses and conferences -- ontario |
| Journal Title: | Journal of Medical Imaging and Radiation Sciences |
| Volume: | 50 |
| Issue: | 1 Suppl. |
| Meeting Dates: | 2019 Apr 1-4 |
| Meeting Location: | Ottawa, Canada |
| ISSN: | 1939-8654 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-03-01 |
| Start Page: | S37 |
| Language: | English |
| ACCESSION: | 135686452 |
| DOI: | 10.1016/j.jmir.2019.03.113 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Source: cin20 |
